Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImpact BioMedical Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2025 | Q3 2025 | N/A | -$0.12 | N/A | N/A | $18.00 K |
| 08/14/2025 | Q2 2025 | N/A | -$1.18 | N/A | N/A | $7.00 K |
| 05/14/2025 | Q1 2025 | N/A | -$0.10 | N/A | N/A | $0 |
| 03/28/2025 | Q4 2024 | N/A | -$2.36 | N/A | N/A | $0 |
| 11/12/2024 | Q3 2024 | N/A | $0.37 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Impact BioMedical Inc. Earnings: FAQ's
Impact BioMedical Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based offlast year's report dates.
The conference call for Impact BioMedical Inc.'s latest earnings report can be listened to online.
The conference call transcript for Impact BioMedical Inc.'s latest earnings report can be read online.
Impact BioMedical Inc. (:IBO) has a recorded annual revenue of $2.33 M.
Impact BioMedical Inc. (:IBO) has a recorded net income of $-2,051,587.Impact BioMedical Inc. has generated $-0.01 earnings per share over the last four quarters.
Impact BioMedical Inc. (:IBO) has a price-to-earnings ratio of -0.15 and price/earnings-to-growth ratio is 0.